tirzepatide/niacinamide injection Tirzepatide is the dual-action one. Instead of working on a single hormone, it targets two — GLP-1 and GIP — which is why it tends to have a stronger effect on appetite We are pleased to announce

The approved starting dose is 2.5 mg, with escalation by 2.5 mg every four weeks to a maximum of 15 mg [4]

Here's the mechanism: the enzyme ALDH2 (aldehyde dehydrogenase 2) oxidises acetaldehyde into acetic acid, but this process requires adequate glutathione reserves to neutralise reactive oxygen species (ROS) generated during the reaction

There is also the possibility that SGLT2 inhibitors could be employed in the treatment of cirrhosis

Low level of methylmercury induce DNA damage to rats: protective effects of selenium

doi: 10.1210/endocr/bqaa093 205 FryarCDCarrollMDOgdenCL

Clinical Update 6/06/2023 Blueberries for Bones The right amount of blueberries may help slow bone loss in postmenopausal women according to a new study